| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | EVP, R&D
2 companies
Leonard John M is a President And CEO at Intellia Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $17.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sell | 34,146 | $9.21 | $314,484.66 | -3.3% | +41.9% | - | |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 88,146 | $9.49 | $836,384.40 | -2.7% | +36.2% | - | |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sell | 26,807 | $12.18 | $326,509.26 | -2.8% | -43.2% | -24.1% | |
| Jan 3, 2024 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sell | 19,223 | $29.46 | $566,309.58 | -2.2% | -14.9% | -58.6% | |
| Jan 4, 2023 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sell | 6,673 | $37.21 | $248,302.33 | -0.9% | -7.5% | -24.6% | |
| Jan 1, 2022 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 2,493 | $112.25 | $279,851.71 | -0.3% | -35.6% | -70.7% | |
| Sep 1, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 121,372 | $160.83 | $19,520,418.44 | -1.5% | -29.9% | -63.4% | |
| Aug 23, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 27,139 | $152.01 | $4,125,416.16 | -1.2% | -21.1% | -61.7% | |
| Aug 19, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 22,682 | $151.28 | $3,431,397.94 | -1.0% | -6.7% | -60.9% | |
| Apr 1, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 38,209 | $83.64 | $3,195,661.00 | -2.7% | +102.2% | -4.9% |